415 related articles for article (PubMed ID: 24224572)
21. Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion.
Albers J; Alles R; Matthée K; Knop K; Nahrup JS; Kleinebudde P
Eur J Pharm Biopharm; 2009 Feb; 71(2):387-94. PubMed ID: 18951978
[TBL] [Abstract][Full Text] [Related]
22. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
23. Milling induced amorphisation and recrystallization of α-lactose monohydrate.
Badal Tejedor M; Pazesh S; Nordgren N; Schuleit M; Rutland MW; Alderborn G; Millqvist-Fureby A
Int J Pharm; 2018 Feb; 537(1-2):140-147. PubMed ID: 29262302
[TBL] [Abstract][Full Text] [Related]
24. Thermal insight of mechanically activated bile acid powders.
Ito T; Byrn S; Chen X; Carvajal MT
Int J Pharm; 2011 Nov; 420(1):68-75. PubMed ID: 21872650
[TBL] [Abstract][Full Text] [Related]
25. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin.
Zhang F; Aaltonen J; Tian F; Saville DJ; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):64-70. PubMed ID: 18703139
[TBL] [Abstract][Full Text] [Related]
26. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.
Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J
Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816
[TBL] [Abstract][Full Text] [Related]
27. Solid-state analysis of amorphous solid dispersions: Why DSC and XRPD may not be regarded as stand-alone techniques.
Dedroog S; Pas T; Vergauwen B; Huygens C; Van den Mooter G
J Pharm Biomed Anal; 2020 Jan; 178():112937. PubMed ID: 31679845
[TBL] [Abstract][Full Text] [Related]
28. In situ controlled crystallization as a tool to improve the dissolution of Glibenclamide.
Elkordy AA; Jatto A; Essa E
Int J Pharm; 2012 May; 428(1-2):118-20. PubMed ID: 22426322
[TBL] [Abstract][Full Text] [Related]
29. X-ray powder diffractometry in combination with principal component analysis--a tool for monitoring solid state changes.
Kogermann K; Veski P; Rantanen J; Naelapää K
Eur J Pharm Sci; 2011 Jul; 43(4):278-89. PubMed ID: 21575718
[TBL] [Abstract][Full Text] [Related]
30. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds.
Patterson JE; James MB; Forster AH; Lancaster RW; Butler JM; Rades T
J Pharm Sci; 2005 Sep; 94(9):1998-2012. PubMed ID: 16052554
[TBL] [Abstract][Full Text] [Related]
31. Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values.
Javadzadeh Y; Mohammadi A; Khoei NS; Nokhodchi A
Acta Pharm; 2009 Jun; 59(2):187-97. PubMed ID: 19564143
[TBL] [Abstract][Full Text] [Related]
32. Effect of ball milling on the physicochemical properties of atorvastatin calcium sesquihydrate: the dissolution kinetic behaviours of milled amorphous solids.
Kobayashi M; Hattori Y; Sasaki T; Otsuka M
J Pharm Pharmacol; 2017 Jan; 69(1):15-22. PubMed ID: 27781276
[TBL] [Abstract][Full Text] [Related]
33. Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability.
Laitinen R; Löbmann K; Grohganz H; Strachan C; Rades T
Mol Pharm; 2014 Jul; 11(7):2381-9. PubMed ID: 24852326
[TBL] [Abstract][Full Text] [Related]
34. In situ amorphisation of indomethacin with Eudragit® E during dissolution.
Priemel PA; Laitinen R; Grohganz H; Rades T; Strachan CJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1259-65. PubMed ID: 24056054
[TBL] [Abstract][Full Text] [Related]
35. Investigation of the milling-induced thermal behavior of crystalline and amorphous griseofulvin.
Trasi NS; Boerrigter SX; Byrn SR
Pharm Res; 2010 Jul; 27(7):1377-89. PubMed ID: 20490628
[TBL] [Abstract][Full Text] [Related]
36. Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy.
Kanaujia P; Lau G; Ng WK; Widjaja E; Schreyer M; Hanefeld A; Fischbach M; Saal C; Maio M; Tan RB
Drug Dev Ind Pharm; 2011 Sep; 37(9):1026-35. PubMed ID: 21417604
[TBL] [Abstract][Full Text] [Related]
37. Thermal degradation of amorphous glibenclamide.
Rehder S; Sakmann A; Rades T; Leopold CS
Eur J Pharm Biopharm; 2012 Jan; 80(1):203-8. PubMed ID: 21907802
[TBL] [Abstract][Full Text] [Related]
38. Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique.
Chauhan B; Shimpi S; Paradkar A
Eur J Pharm Sci; 2005 Oct; 26(2):219-30. PubMed ID: 16087324
[TBL] [Abstract][Full Text] [Related]
39. Co-Amorphous Combination of Nateglinide-Metformin Hydrochloride for Dissolution Enhancement.
Wairkar S; Gaud R
AAPS PharmSciTech; 2016 Jun; 17(3):673-81. PubMed ID: 26314243
[TBL] [Abstract][Full Text] [Related]
40. Screening for differences in the amorphous state of indomethacin using multivariate visualization.
Savolainen M; Heinz A; Strachan C; Gordon KC; Yliruusi J; Rades T; Sandler N
Eur J Pharm Sci; 2007 Feb; 30(2):113-23. PubMed ID: 17169536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]